Home › Ischemic Stroke › NCT07436156

SUMMIT RISE Study of Acute Ischemic Stroke Patients

SUMMIT RISE Study of Acute Ischemic Stroke Patients Evaluating the Route 92 Medical Reperfusion Systems.

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Acute ischemic stroke patient initially treated (first pass) with a Route 92 Medical Reperfusion System
* Informed consent completed and documented within 72 hours following thrombectomy procedure
* Endovascular treatment initiated (defined as time of groin puncture) within 8 hours from time last known well
* Age ≥ 18 years

Exclusion Criteria:

* None

About the study

SUMMIT RISE Study of Acute Ischemic Stroke Patients

What is being tested

• Route 92 Medical Reperfusion Systems (device)

Sponsor: Route 92 Medical, Inc. · Participants: 500 · Started: Feb 12, 2026

Contact the study team

• Renee Kochevar Vice President, Clinical Research, PhD, ALM · Phone: 650-581-1179

Official record on ClinicalTrials.gov — NCT07436156

Locations in the U.S.

Conditions

• Ischemic Stroke

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.